Gsa Capital Partners LLP Repare Therapeutics Inc. Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 117,296 shares of RPTX stock, worth $131,371. This represents 0.01% of its overall portfolio holdings.
Number of Shares
117,296
Previous 240,522
51.23%
Holding current value
$131,371
Previous $827,000
81.38%
% of portfolio
0.01%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding RPTX
# of Institutions
59Shares Held
33.6MCall Options Held
51KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$11.6 Million0.51% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$3.86 Million1.93% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$3.72 Million0.12% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$3.32 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$2.96 Million5.13% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $47M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...